These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30251669)
1. Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells. Sinha BK; Bortner CD; Mason RP; Cannon RE Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2806-2814. PubMed ID: 30251669 [TBL] [Abstract][Full Text] [Related]
2. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells. Sinha BK; Perera L; Cannon RE Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952 [TBL] [Abstract][Full Text] [Related]
3. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
4. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites. Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239 [TBL] [Abstract][Full Text] [Related]
5. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Mi Y; Lou L Br J Cancer; 2007 Oct; 97(7):934-40. PubMed ID: 17912240 [TBL] [Abstract][Full Text] [Related]
6. BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo. Zhang DM; Shu C; Chen JJ; Sodani K; Wang J; Bhatnagar J; Lan P; Ruan ZX; Xiao ZJ; Ambudkar SV; Chen WM; Chen ZS; Ye WC Mol Pharm; 2012 Nov; 9(11):3147-59. PubMed ID: 23046348 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Zhu CY; Lv YP; Yan DF; Gao FL Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601 [TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
9. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein. Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160 [No Abstract] [Full Text] [Related]
10. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561 [TBL] [Abstract][Full Text] [Related]
11. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
13. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
14. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137 [TBL] [Abstract][Full Text] [Related]
15. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
16. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301 [TBL] [Abstract][Full Text] [Related]
17. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells. Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846 [TBL] [Abstract][Full Text] [Related]
18. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
19. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
20. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]